Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2006 by University of California, Los Angeles.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
AIDS Research Alliance
Johns Hopkins Bloomberg School of Public Health
Information provided by:
University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00377221
First received: September 14, 2006
Last updated: September 15, 2006
Last verified: September 2006
  Purpose

Observational, cross-sectional, single-visit study of 896 men and women in Los Angeles, CA and Baltimore, MD including a computer-assisted interview focusing on the behavioral repertoire surrounding RAI, symptoms, and health seeking behaviors and a multidimensional assessment of behaviors, anorectal examination, and testing for sexually transmitted infections (STIs).


Condition
Rectal Health
Rectal Behaviors
Anorectal Symptomatology

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Official Title: Rectal Health, Behaviors and Microbicide Acceptability

Further study details as provided by University of California, Los Angeles:

Estimated Enrollment: 896
Study Start Date: September 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

Men and women are eligible who meet all of the following criteria:

  1. At least 18 years of age
  2. Willing to be tested for STIs including HIV
  3. Willing to undergo an anal exam
  4. Mentally competent to understand study procedures and give informed consent.
  5. For the NO-RAI groups:

    No RAI in the past year for the non-RAI men and women

  6. For the practicing RAI groups:

Males: report RAI in the past 30 days Females: report RAI in the past 12 months

Exclusion Criteria:

  1. Less than 18 years of age
  2. Unwilling to be tested for STIs (and HIV)
  3. Unwilling to undergo an anal exam
  4. Unwilling to complete study questionnaire
  5. Not mentally competent to understand study procedures and give informed consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00377221

Locations
United States, California
AIDS Research Alliance Recruiting
Los Angeles, California, United States, 90069
Contact: Michelle Vertucci, NP/PA    310-358-2429      
Principal Investigator: Stephen Brown, MD         
Principal Investigator: Marjan Hezareh, PhD         
United States, Maryland
Johns Hopkins University Recruiting
Baltimore, Maryland, United States, 21205
Contact: Yasmeen Long    410-502-5949    ylong@jhsph.edu   
Principal Investigator: John Hylton, PhD         
Sponsors and Collaborators
University of California, Los Angeles
AIDS Research Alliance
Johns Hopkins Bloomberg School of Public Health
Investigators
Principal Investigator: Pamina Gorbach, DrPH University of California, Los Angeles
Principal Investigator: Peter A Anton, MD University of California, Los Angeles
Principal Investigator: Ross Cranston, MD University of California, Los Angeles
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00377221     History of Changes
Other Study ID Numbers: U19-AI060614:P3 Aim1, 05-07-098, H.34.05.08.24, ARA010
Study First Received: September 14, 2006
Last Updated: September 15, 2006
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 18, 2014